John Albert Ridgway

age ~85

from Walnut Creek, CA

Get Report

Also known as:

John A Ridgway
John J Ridgway
Johnny J Ridgway
Johnny J Ridgeway

Phone and address:: 905 Savannah Ct, Walnut Creek, CA 94598
(925)8998259

Connected to:

John Ridgway Phones & Addresses

905 Savannah Ct, Walnut Creek, CA 94598 • (925)8998259 • (925)6769117
San Leandro, CA
Las Vegas, NV
Henderson, NV
905 Savannah Ct, Walnut Creek, CA 94598 • (925)8998259

Work

Position:

Homemaker

Education

Degree:

Graduate or professional degree

Images

Emails

j***[email protected]

Specialities

Criminal Defense • Juvenile Law • Real Estate • Speeding & Traffic Ticket

Medicine Doctors

John G. Ridgway

view source

Specialties:

Family Medicine

Work:

Prime Care Central
284 W 32 St, Yuma, AZ 85364
(928)3414563 (phone), (928)3442055 (fax)

Education:

Medical School
A.T. Still University of Health Sciences/ Kirksville College of Osteopathic Medicine
Graduated: 1983

Procedures:

Arthrocentesis
Destruction of Benign/Premalignant Skin Lesions
Electrocardiogram (EKG or ECG)
Vaccine Administration

Conditions:

Acute Bronchitis
Acute Conjunctivitis
Acute Pharyngitis
Acute Sinusitis
Acute Upper Respiratory Tract Infections

Languages:

English
Spanish

Description:

Dr. Ridgway graduated from the A.T. Still University of Health Sciences/ Kirksville College of Osteopathic Medicine in 1983. She works in Yuma, AZ and specializes in Family Medicine. Dr. Ridgway is affiliated with Yuma Regional Medical Center.

Amazon

The BOZZ Chronicles (Dover Graphic Novels)

view source

"This is fantastic stuff." — Brandon Graham (Prophet)The first single-volume collection of the six-part Epic Comics cult favorite, Michelinie (Iron Man) and Blevins's (The New Mutants) daring graphic novel follows the adventures of a suicidal alien, a plucky prostitute, and a raucous American cowboy...

Author
David Michelinie

Binding
Paperback

Pages
224

Publisher
Dover Publications

ISBN #
0486798518

EAN Code
9780486798516

ISBN #
5

John Constantine, Hellblazer, Vol. 1: Original Sins

view source

The very first Hellblazer collection ORIGINAL SINS is available in a new edition that includes John Constantine’s appearances in SWAMP THING. This is the first of a series of new HELLBLAZER editions starring Vertigo’s longest running antihero, John Constantine, England’s chain-smoking, low-rent magu...

Author
Jamie Delano, Rick Veitch

Binding
Paperback

Pages
304

Publisher
Vertigo

ISBN #
1401230067

EAN Code
9781401230067

ISBN #
1

The Trenchcoat Brigade #1

view source

Mister E has arrived in the present day, but why is he killing green-eyed Russian men in New York City? E’s reluctant allies join him on a search for the answer, voyaging through time and space to a devastated future ruled by an evil force.

Author
John,Ney Rieber

Binding
Kindle Edition

Pages
24

Publisher
Vertigo

ISBN #
3

Doctor Who: Prisoners of Time Volume 2

view source

Doctor Who's 50th Anniversary celebration continues in Prisoners of Time Volume 2! The 5th through 8th Doctors get a turn from writers Scott and David Tipton, and artists Philip Bond, John Ridgway, Andres Ponce, and Horacio Domingues.

Author
Scott Tipton, David Tipton

Binding
Paperback

Pages
104

Publisher
IDW Publishing

ISBN #
1613777558

EAN Code
9781613777558

ISBN #
2

Babylon 5, No. 5: Shadows- Past and Present

view source

This is a comic book.

Author
Tim Dehaas

Binding
Comic

Pages
32

Publisher
DC Comics

ISBN #
9

Scientific Illustration

view source

Author
John L. Ridgway

Binding
Hardcover

Pages
187

Publisher
STANFORD UNIVERSITY PRESS

ISBN #
1114700150

EAN Code
9781114700154

ISBN #
8

Lawyers & Attorneys

John Ridgway - Lawyer

view source

Specialties:

Criminal Defense
Juvenile Law
Real Estate
Speeding & Traffic Ticket

ISLN:

911305959

Admitted:

1981

University:

Wilmington College, B.S., 1974

Law School:

John Marshall Law School, J.D., 1981

Name / Title

Company / Classification

Phones & Addresses

John Ridgway
Managing

WHB STORAGE, LLC

John R Ridgway

ETDBW ENTERPRISES, INC

Wikipedia

John Ridgway (sailor)

view source

John Ridgway, MBE, (born 1938), is a British yachtsman and rower. Biography. Ridgway was educated at Pangbourne Nautical College and Royal Military Academy ...

John Ridgway (comic artist)

view source

John Ridgway (born May 4, 1940) is a British comics artist. Contents. 1 ...

John Ridgway

view source

John Ridgway may refer to: John Livzey Ridgway (18591947), American nature ...

Resumes

John Ridgway

view source

Skills:

Contract Negotiation
Construction Management
Microsoft Office
Process Improvement
Energy
Refineries
Petroleum
Petrochemical
Oil
Factory

John Ridgway

view source

John Ridgway

view source

John Ridgway

view source

John Ridgway

view source

Location:

United States

Us Patents

Antibodies For Cancer Therapy And Diagnosis
view source
US Patent:

7288249, Oct 30, 2007
Filed:

May 28, 2003
Appl. No.:

10/447331
Inventors:

Paul J. Carter - San Francisco CA, US
John B. Ridgway - Pacifica CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

A61K 39/395
C07K 16/00
US Classification:

4241301, 4241381, 4241411, 4241551, 5303871, 5303877, 5302881, 5303888
Abstract:

The present application describes a method for making antibodies which can be used for cancer diagnosis or therapy. The application also discloses a method for identifying an antigen which is differentially expressed on the surface of two or more distinct cell populations. The application additionally describes human antibodies directed against decay accelerating factor (DAF), as well as therapeutic compositions comprising such antibodies. Moreover, the application discloses a method of treating lung cancer with antibodies directed against DAF.

Method For Making Heteromultimeric Polypeptides
view source
US Patent:

7642228, Jan 5, 2010
Filed:

Dec 7, 2001
Appl. No.:

10/010245
Inventors:

Paul J. Carter - San Francisco CA, US
Leonard G. Presta - San Francisco CA, US
John B. Ridgway - San Francisco CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

A61K 39/395
A61K 38/16
C07K 14/00
C07K 16/00
C07K 16/46
C07K 19/00
US Classification:

514 2, 530300, 530350, 5303871, 5303873, 4241301, 4241331, 4241361, 4241781
Abstract:

The invention relates to a method of preparing heteromultimeric polypeptides such as bispecific antibodies, bispecific immunoadhesins and antibody-immunoadhesin chimeras. The invention also relates to the heteromultimers prepared using the method. Generally, the method involves introducing a protuberance at the interface of a first polypeptide and a corresponding cavity in the interface of a second polypeptide, such that the protuberance can be positioned in the cavity so as to promote heteromultimer formation and hinder homomultimer formation. “Protuberances” are constructed by replacing small amino acid side chains from the interface of the first polypeptide with larger side chains (e. g. tyrosine or tryptophan). Compensatory “cavities” of identical or similar size to the protuberances are created in the interface of the second polypeptide by replacing large amino acid side chains with smaller ones (e. g.

Knobs And Holes Heteromeric Polypeptides
view source
US Patent:

7695936, Apr 13, 2010
Filed:

Sep 20, 2006
Appl. No.:

11/533709
Inventors:

Paul J. Carter - San Francisco CA, US
Leonard G. Presta - San Francisco CA, US
John B. Ridgway - San Francisco CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

C07K 16/00
C07K 16/46
C07K 19/00
C07K 14/00
A61K 39/395
C12N 5/10
US Classification:

435 691, 435 697, 435 701, 435 711, 435325, 530350, 5303871, 5303873, 530300, 4241301, 4241331, 4241361, 4241781
Abstract:

The invention relates to a method of preparing heteromultimeric polypeptides such as bispecific antibodies, bispecific immunoadhesins and antibody-immunoadhesin chimeras. The invention also relates to the heteromultimers prepared using the method. Generally, the method involves introducing a protuberance at the interface of a first polypeptide and a corresponding cavity in the interface of a second polypeptide, such that the protuberance can be positioned in the cavity so as to promote heteromultimer formation and hinder homomultimer formation. “Protuberances” are constructed by replacing small amino acid side chains from the interface of the first polypeptide with larger side chains (e. g. tyrosine or tryptophan). Compensatory “cavities” of identical or similar size to the protuberances are created in the interface of the second polypeptide by replacing large amino acid side chains with smaller ones (e. g.

Knobs And Holes Heteromeric Polypeptides
view source
US Patent:

8216805, Jul 10, 2012
Filed:

Feb 4, 2010
Appl. No.:

12/700618
Inventors:

Paul J. Carter - San Francisco CA, US
Leonard G. Presta - San Francisco CA, US
John B. Ridgway - San Francisco CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

A61K 39/395
C07K 14/00
C07K 16/00
C07K 16/46
C07K 19/00
C12N 5/10
US Classification:

435 691, 435 697, 435 701, 435 711, 435325, 530350, 5303871, 5303873, 530300, 4241301, 4241331, 4241361, 4241781
Abstract:

The invention relates to a method of preparing heteromultimeric polypeptides such as bispecific antibodies, bispecific immunoadhesins and antibody-immunoadhesin chimeras. The invention also relates to the heteromultimers prepared using the method. Generally, the method involves introducing a protuberance at the interface of a first polypeptide and a corresponding cavity in the interface of a second polypeptide, such that the protuberance can be positioned in the cavity so as to promote heteromultimer formation and hinder homomultimer formation. “Protuberances” are constructed by replacing small amino acid side chains from the interface of the first polypeptide with larger side chains (e. g. tyrosine or tryptophan). Compensatory “cavities” of identical or similar size to the protuberances are created in the interface of the second polypeptide by replacing large amino acid side chains with smaller ones (e. g.

Taci And Br3 Polypeptides And Uses Thereof
view source
US Patent:

20050070689, Mar 31, 2005
Filed:

Jul 24, 2002
Appl. No.:

10/485489
Inventors:

Vishva Dixit - Los Altos CA, US
Iqbal Grewal - Fremont CA, US
John Ridgway - San Francisco CA, US
Minhong Yan - Burlingame CA, US
Assignee:

GENENTECH, INC. - South San Francisco CA
International Classification:

C07K014/705
C07H021/04
C12N001/18
C12N005/06
C12N015/74
US Classification:

530350000, 536023500, 435069100, 435252330, 435254200, 435358000, 435320100, 435006000
Abstract:

Novel, receptors, referred to herein as “TACIs” and “BR3”, agonists and antagonists thereof, and method of using TACIs and BR3, as well as agonists and antagonists thereof, to modulate, for example, activity of tumor necrosis factor (TNF) and TNFR-related molecules, including members of the TNF and TNFR families referred to as TALL-1, APRIL, TACI, and BCMA, are provided. Methods for in vitro, in situ, and/or in vivo diagnosis and/or treatment of mammalian cells or pathological conditions associated with such TNF and TNFR-related molecules are further provided.

Antibodies For Cancer Therapy And Diagnosis
view source
US Patent:

20080166698, Jul 10, 2008
Filed:

Jun 19, 2007
Appl. No.:

11/765336
Inventors:

PAUL J. CARTER - San Francisco CA, US
John B. Ridgway - Pacifica CA, US
International Classification:

C12Q 1/70
C07K 16/30
US Classification:

435 5, 5303871
Abstract:

The present application describes a method for making antibodies which can be used for cancer diagnosis or therapy. The application also discloses a method for identifying an antigen which is differentially expressed on the surface of two or more distinct cell populations. The application additionally describes human antibodies directed against decay accelerating factor (DAF), as well as therapeutic compositions comprising such antibodies. Moreover, the application discloses a method of treating lung cancer with antibodies directed against DAF.

Method For Making Heteromultimeric Polypeptides
view source
US Patent:

20130089553, Apr 11, 2013
Filed:

Jun 12, 2012
Appl. No.:

13/494870
Inventors:

Paul J. Carter - San Francisco CA, US
Leonard G. Presta - San Francisco CA, US
John B. Ridgway - San Francisco CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

C07K 16/46
US Classification:

4241361, 5303873, 435 696, 4352542
Abstract:

The invention relates to a method of preparing heteromultimeric polypeptides such as bispecific antibodies, bispecific immunoadhesins, heteromultimers and antibody-immunoadhesin chimeras. Generally, the method involves introducing a protuberance at the interface of a first polypeptide and a corresponding cavity in the interface of a second polypeptide, such that the protuberance can be positioned in the cavity so as to promote heteromultimer formation and hinder homomultimer formation. The protuberance and cavity can be made by synthetic means such as altering the nucleic acid encoding the polypeptides or by peptide synthesis.

Method For Making Heteromultimeric Polypeptides
view source
US Patent:

57311684, Mar 24, 1998
Filed:

Mar 1, 1995
Appl. No.:

8/399106
Inventors:

Paul J. Carter - San Francisco CA
Leonard G. Presta - San Francisco CA
John B. Ridgway - San Francisco CA
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

C12D 2106
US Classification:

435 691
Abstract:

The invention relates to a method of preparing heteromultimeric polypeptides such as bispecific antibodies, bispecific immunoadhesins and antibody-immunoadhesin chimeras. The invention also relates to the heteromultimers prepared using the method. Generally, the method involves introducing a protuberance at the interface of a first polypeptide and a corresponding cavity in the interface of a second polypeptide, such that the protuberance can be positioned in the cavity so as to promote heteromultimer formation and hinder homomultimer formation. "Protuberances" are constructed by replacing small amino acid side chains from the interface of the first polypeptide with larger side chains (e. g. tyrosine or tryptophan). Compensatory "cavities" of identical or similar size to the protuberances are created in the interface of the second polypeptide by replacing large amino acid side chains with smaller ones (e. g.

Wikipedia References

John Ridgway

About:

Born:

04 May 1940

Work:

Position:

Engineer • Artist

Skills & Activities:

Activity:

British comics artist

Skill:

Computer graphics • IDEAL (CA) • Professional

John Ridgway

About:

Born:

1938

Work:

Position:

Sailor • Captain

Education:

Studied at:

Pangbourne College

Skills & Activities:

Sport:

English rower

Plaxo

John Ridgway

view source

John Ridgway

view source

Taneytown MD

John Ridgway

view source

HILTON HOTELS

John Ridgway

view source

Iowa Utilities Board

Classmates

La Rue High School, La ru...

view source

Graduates:

John Ridgway (1939-1943),
Gary Christian (1955-1960)

Los Alamos Middle School,...

view source

Graduates:

Chelsea Christensen (1994-1996),
Carolyn Haggard (1994-1995),
Emily Akin (1998-2002),
John Ridgway (1951-1954),
William Schofield (1995-1998)

Phoebe Hearst Elementary ...

view source

Graduates:

Teri Jackson (1968-1972),
Charrell Booth (1996-2001),
John Ridgway (1977-1977),
Jesus Figueroa (1979-1982)

Dickinson School of Law, ...

view source

Graduates:

John Ridgway (1989-1992),
Beth Krusen (1984-1988),
Jason Paul Demont (1987-1990),
Kerry Voss (1985-1988),
Michael Rogovin (1995-1999)

Googleplus

John Ridgway

News

Coping Strategies of Ocean Castaways Hold Lessons for the COVID Pandemic

view source

xcruciating hunger may be fought by comparing it with real famine or with the precarious situation in which many elderly people live. In 1966 then British paratroopers John Ridgway and Chay Blyth became the second team ever to row across the Atlantic in an open dorybraving storms, cold and near starvation. A
Date: Apr 16, 2021
Category: More news
Source: Google

Before Harry Potter: Meet the Other British Boys Who Explored the World of Magic

view source

The creation of Alan McKenzie and artist John Ridgway, the mythology of Luke Kirby was at once more restrained he was merely to be the heir to the "Kirby legacy," and the greatest alchemist ever, not overall magician and more melodramatic than either Potter or Hunter; trained in the ways of magi
Date: Nov 17, 2016
Category: Entertainment
Source: Google